RxDoctor Payments Data

Jenna Schrage, NP

Nurse Practitioner · Springfield, ILNPI 1740728039

Payments from drug & device makers

$10,170in general payments, 2019–2025

Across 228 payments — averaging $44.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$6K
  • Optinose US, Inc.$1K
  • Jazz Pharmaceuticals Inc.$980
  • Sanofi$426
  • Regeneron Healthcare Solutions, Inc.$412
  • GSK$378
  • plus $585 from 6 others

What the payments were for

  • Consulting fees$3503%
  • Speaking & faculty fees$4,75047%
  • Travel & lodging$9089%
  • Food & beverage$3,95539%
  • Education$2072%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,170 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$134,647
Medicare patients
758
Services billed
2,652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SunosiSolriamfetol Hcl16$14,857
XhanceFluticasone Propionate11$9,934
Omeprazole346$3,873
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth33$3,635
Epinephrine15$2,900
Ipratropium Bromide66$2,143
Fluticasone Propionate112$1,705
Azelastine Hcl49$1,172
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav37$417
Ropinirole Hcl44$318
Famotidine33$272
Trazodone Hcl44$242
Fluconazole14$218
Methylprednisolone21$123
Montelukast Sodium28$104

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Axsome Therapeutics, Inc.Sunosi$6,198$14,85716 claims
Optinose US, Inc.Xhance$1,191$9,93411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Springfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →